These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

866 related items for PubMed ID: 30107892

  • 21. The use of prolonged-release melatonin in circadian medicine: a systematic review.
    Del Casale A, Arena JF, Giannetti F, Minervino A, Biggio G, Girardi P.
    Minerva Med; 2024 Apr; 115(2):125-142. PubMed ID: 38713204
    [Abstract] [Full Text] [Related]

  • 22. [Melatonin for the regulation of sleep and other biological rhythms].
    Zhdanova IV, Poluectov MG.
    Zh Nevrol Psikhiatr Im S S Korsakova; 2024 Apr; 124(5. Vyp. 2):8-13. PubMed ID: 38934660
    [Abstract] [Full Text] [Related]

  • 23. Nightly treatment of primary insomnia with prolonged release melatonin for 6 months: a randomized placebo controlled trial on age and endogenous melatonin as predictors of efficacy and safety.
    Wade AG, Ford I, Crawford G, McConnachie A, Nir T, Laudon M, Zisapel N.
    BMC Med; 2010 Aug 16; 8():51. PubMed ID: 20712869
    [Abstract] [Full Text] [Related]

  • 24. Melatonin--the key to the gate of sleep.
    Shochat T, Haimov I, Lavie P.
    Ann Med; 1998 Feb 16; 30(1):109-14. PubMed ID: 9556097
    [Abstract] [Full Text] [Related]

  • 25. Entrainment of free-running circadian rhythms by melatonin in blind people.
    Sack RL, Brandes RW, Kendall AR, Lewy AJ.
    N Engl J Med; 2000 Oct 12; 343(15):1070-7. PubMed ID: 11027741
    [Abstract] [Full Text] [Related]

  • 26. Improvement of sleep quality in elderly people by controlled-release melatonin.
    Garfinkel D, Laudon M, Nof D, Zisapel N.
    Lancet; 1995 Aug 26; 346(8974):541-4. PubMed ID: 7658780
    [Abstract] [Full Text] [Related]

  • 27. [Therapeutic approaches for sleep and rhythms disorders in children with ASD].
    Schröder CM, Broquère MA, Claustrat B, Delorme R, Franco P, Lecendreux M, Tordjman S.
    Encephale; 2022 Jun 26; 48(3):294-303. PubMed ID: 35120753
    [Abstract] [Full Text] [Related]

  • 28. Searching for new options for treating insomnia: are melatonin and ramelteon beneficial?
    Bellon A.
    J Psychiatr Pract; 2006 Jul 26; 12(4):229-43. PubMed ID: 16883148
    [Abstract] [Full Text] [Related]

  • 29. Melatonin (MEL) and its use in neurological diseases and insomnia: Recommendations of the French Medical and Research Sleep Society (SFRMS).
    Vecchierini MF, Kilic-Huck U, Quera-Salva MA, Members of the MEL consensus group of the SFRMS.
    Rev Neurol (Paris); 2021 Mar 26; 177(3):245-259. PubMed ID: 32921425
    [Abstract] [Full Text] [Related]

  • 30. Case series of perimenopausal women with insomnia treated with mirtazapine followed by prolonged-release melatonin add-on and monotherapy.
    Dolev Z.
    Arch Womens Ment Health; 2011 Jun 26; 14(3):269-73. PubMed ID: 21311927
    [Abstract] [Full Text] [Related]

  • 31. Effect of melatonin-rich night-time milk on sleep and activity in elderly institutionalized subjects.
    Valtonen M, Niskanen L, Kangas AP, Koskinen T.
    Nord J Psychiatry; 2005 Jun 26; 59(3):217-21. PubMed ID: 16195124
    [Abstract] [Full Text] [Related]

  • 32. The effect of prolonged-release melatonin on sleep measures and psychomotor performance in elderly patients with insomnia.
    Luthringer R, Muzet M, Zisapel N, Staner L.
    Int Clin Psychopharmacol; 2009 Sep 26; 24(5):239-49. PubMed ID: 19584739
    [Abstract] [Full Text] [Related]

  • 33. [Melatonin as a regulator of human sleep and circadian systems].
    Mishima K.
    Nihon Rinsho; 2012 Jul 26; 70(7):1139-44. PubMed ID: 22844795
    [Abstract] [Full Text] [Related]

  • 34. Some implications of melatonin use in chronopharmacology of insomnia.
    Golombek DA, Pandi-Perumal SR, Brown GM, Cardinali DP.
    Eur J Pharmacol; 2015 Sep 05; 762():42-8. PubMed ID: 26004526
    [Abstract] [Full Text] [Related]

  • 35. Melatonin agonist tasimelteon (VEC-162) for transient insomnia after sleep-time shift: two randomised controlled multicentre trials.
    Rajaratnam SM, Polymeropoulos MH, Fisher DM, Roth T, Scott C, Birznieks G, Klerman EB.
    Lancet; 2009 Feb 07; 373(9662):482-91. PubMed ID: 19054552
    [Abstract] [Full Text] [Related]

  • 36. Melatonin improves sleep quality of patients with chronic schizophrenia.
    Shamir E, Laudon M, Barak Y, Anis Y, Rotenberg V, Elizur A, Zisapel N.
    J Clin Psychiatry; 2000 May 07; 61(5):373-7. PubMed ID: 10847313
    [Abstract] [Full Text] [Related]

  • 37. Melatonergic drugs in clinical practice.
    Hardeland R, Poeggeler B, Srinivasan V, Trakht I, Pandi-Perumal SR, Cardinali DP.
    Arzneimittelforschung; 2008 May 07; 58(1):1-10. PubMed ID: 18368944
    [Abstract] [Full Text] [Related]

  • 38. Circadian rhythm sleep disorders: pathophysiology and potential approaches to management.
    Zisapel N.
    CNS Drugs; 2001 May 07; 15(4):311-28. PubMed ID: 11463135
    [Abstract] [Full Text] [Related]

  • 39. Clinical Sleep-Wake Disorders II: Focus on Insomnia and Circadian Rhythm Sleep Disorders.
    Spiegelhalder K, Nissen C, Riemann D.
    Handb Exp Pharmacol; 2019 May 07; 253():261-276. PubMed ID: 28707143
    [Abstract] [Full Text] [Related]

  • 40. Efficacy of melatonin as a hypnotic agent.
    Mendelson WB.
    J Biol Rhythms; 1997 Dec 07; 12(6):651-6. PubMed ID: 9406041
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 44.